The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype

Immunity
S J Morrison, I L Weissman

Abstract

The Thy-1.1loSca-1hiLin-/lo population, representing 0.05% of C57BL/Ka-Thy-1.1 bone marrow, is highly enriched for hematopoietic stem cells and includes all multipotent progenitors in this mouse strain; however, the functional reconstituting activity of this fraction is heterogeneous. Only around 25% of clonal reconstitutions by cells from this population are long term; remaining clones yield transient multilineage reconstitutions. By fractionating based on lineage marker expression, the Thy-1.1loSca-1hiLin-/lo population has been resolved into three subpopulations: Lin-Mac-1-CD4-; Lin-Mac-1loCD4-; and Mac-1loCD4lo. Of these, only the Lin-Mac-1-CD4- population is highly enriched for long-term reconstituting hematopoietic stem cells. A comparison of transient and long-term multipotent progenitors indicates that long-term progenitors have less CFU-S activity, are equally radioprotective, and are less frequently in cell cycle. The ability to predict the longevity of reconstitution based on lineage marker expression indicates that reconstitution potential is deterministic, not stochastic.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·S HellmanR M Vigneulle
Jan 1, 1979·Cell and Tissue Kinetics·M RosendaalT R Bradley
Sep 1, 1976·The Journal of Clinical Investigation·J T DanceyC A Finch
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K Ikuta, I L Weissman
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
Nov 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D E Harrison, R K Zhong
May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L M Spain, R C Mulligan
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L G SmithS Heimfeld
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·G J Spangrude, G R Johnson
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·B CapelB Mintz
Apr 1, 1989·The Journal of Experimental Medicine·G G Frederickson, R S Basch
Jul 1, 1988·Science·G J SpangrudeI L Weissman
Apr 1, 1993·Current Opinion in Immunology·N UchidaI L Weissman

❮ Previous
Next ❯

Citations

Jul 13, 2002·The Journal of Pathology·Dominique Bonnet
May 28, 2010·Journal of the History of Biology·Melinda Bonnie Fagan
May 10, 2007·Current Neurology and Neuroscience Reports·Georgia Panagiotakos, Viviane Tabar
Sep 27, 2008·Immunologic Research·Daniel L Northrup, David Allman
Apr 1, 1995·Current Opinion in Immunology·H R Rodewald
Jan 22, 2004·Archives of Medical Research·Stephen J Szilvassy
Mar 11, 2004·The International Journal of Biochemistry & Cell Biology·Ilaria Bellantuono
Apr 30, 2013·Cancer Letters·Anja SchillertMartin R Sprick
Oct 27, 2007·Cellular Immunology·Hillary H NorrisRobert Chervenak
Sep 24, 2013·Trends in Immunology·Jianhua YuMichael A Caligiuri
Mar 29, 2008·Cell Stem Cell·Ravindra MajetiIrving L Weissman
May 26, 1999·Experimental Hematology·J ChenD E Harrison
Jan 5, 2002·Experimental Gerontology·Rita B Effros, Amiela Globerson
Apr 11, 2001·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D Metcalf
Mar 1, 2002·Current Opinion in Immunology·Christine BorowskiHarald von Boehmer
Apr 1, 1997·Current Opinion in Immunology·S J MorrisonI L Weissman
Mar 14, 2000·Current Opinion in Immunology·K AkashiI L Weissman
Nov 30, 2002·Seminars in Immunology·Susan S ProhaskaMotonari Kondo
Aug 23, 2002·Immunological Reviews·Irving L Weissman
Oct 9, 2002·Immunological Reviews·Andris AvotsAlbrecht M Müller
Oct 9, 2002·Immunological Reviews·Antonius G RolinkFritz Melchers
Oct 9, 2002·Immunological Reviews·Paul W KincadeMaria Isabel D Rossi
Sep 19, 2008·Leukemia·N MisaghianJ A McCubrey
Sep 21, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Ossama AbbasMeera Mahalingam
Sep 2, 2004·Nature Cell Biology·Jason Pomerantz, Helen M Blau
Oct 6, 2009·Nature Genetics·Ann-Marie BröskeFrank Rosenbauer
Jan 24, 2012·Nature Immunology·See Heng WongAndrew N J McKenzie
Jun 30, 2004·Nature Immunology·David T Scadden
Oct 21, 2006·Nature Immunology·Gay M Crooks, Kenneth Weinberg
Mar 7, 2006·Nature Immunology·Toshimi YoshidaKatia Georgopoulos
Apr 24, 2007·Nature Immunology·Kang LiuMichel Nussenzweig
Sep 1, 1996·Nature Medicine·S J MorrisonI L Weissman
Dec 1, 1996·Nature Medicine·M Vickers
Dec 13, 2005·Nature Medicine·Jennifer J TrowbridgeMickie Bhatia
Jul 14, 2010·Nature Methods·Mazhar AdliBradley E Bernstein
Jan 22, 2008·Nature Reviews. Immunology·Robert S WelnerPaul W Kincade
Mar 8, 2008·Nature Reviews. Immunology·Mark J Kiel, Sean J Morrison
Feb 26, 2010·Nature Reviews. Immunology·Andreas TrumppAnne Wilson
Jun 11, 2011·Nature Reviews. Immunology·Howard Cedar, Yehudit Bergman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CZI Human Cell Atlas Seed Network

The aim of the Human Cell Atlas (HCA) is to build reference maps of all human cells in order to enhance our understanding of health and disease. The Seed Networks for the HCA project aims to bring together collaborators with different areas of expertise in order to facilitate the development of the HCA. Find the latest research from members of the HCA Seed Networks here.